Page 177 - Tata_Chemicals_yearly-reports-2019-20
P. 177

Integrated report             Statutory reportS          Financial StatementS
                                                                                    Standalone



            Standalone Statement of Profit and Loss for the year ended March 31, 2020
                                                                                                       ` in crore
                                                                                         Year ended   Year ended
                                                                                Note  March 31, 2020  March 31, 2019
                                                                                                       (Restated)

             I.   Revenue from operations                                        25        2,920.29     3,121.25
             II.   Other income                                                  26         309.15        400.32
             III.   Total income (I+II)                                                    3,229.44     3,521.57
             IV.  Expenses
                 a)   Cost of materials consumed                                            541.90        566.77
                 b)   Purchases of stock-in-trade                                            94.41        101.97
                 c)   Changes in inventories of finished goods, work-in-progress and stock-in-trade  27  (76.41)  75.50
                 d)   Employee benefits expense                                  28         250.28        226.85
                 e)   Finance costs                                              29          43.37        86.14
                 f)   Depreciation and amortisation expense                      30         149.50        140.34
                 g)   Other expenses                                             31        1,392.07     1,463.52
                 Total expenses (a to g)                                                   2,395.12     2,661.09
             V.   Profit before tax ( III - IV )                                            834.32       860.48
             VI.   Tax expense
                 (a)   Current tax                                               33         194.37        244.73
                 (b)   Deferred tax                                              33         (31.87)      (15.06)
                 Total tax expense (VI (a) + VI (b))                                        162.50       229.67
             VII.  Profit for the year from continuing operations ( V-VI)                   671.82       630.81
             VIII.  Profit before tax from discontinued operations               34             -         293.18
             IX.   Exceptional gain from discontinued operations (net)           34        6,128.08          -
             X.   Tax expense of discontinued operations                         34         (40.32)       69.15
             XI.   Profit for the year from discontinued operations ( VIII+IX-X)           6,168.40      224.03
             XII.  Profit for the year (VII+XI)                                            6,840.22      854.84
             XIII.  Other comprehensive income (net of tax) ("OCI")
                 (A)   Items that will not be reclassified to the Standalone Statement of Profit and Loss
                     -   Changes in fair value of investments in equities carried at fair value through OCI  (557.31)  268.59
                     -   Remeasurement of defined employee benefit plans (note 38)          (50.55)       (2.97)
                 (B)     Income tax relating to items that will not be reclassified to the Standalone Statement of   (65.42)  32.63
                     Profit and Loss
                 Total other comprehensive income (net of tax) (A-B)                       (542.44)      232.99
             XIV.  Total comprehensive income for the year (XII + XIII)                    6,297.78     1,087.83
             XV.  Earnings per share for continuing operations (in `)
                 -   Basic and Diluted                                           35          26.37        24.76
             XVI.  Earnings per share for discontinued operations (in `)
                 -   Basic and Diluted                                           35         242.13         8.79
             XVII.  Earnings per share (for continuing and discontinued operations) (in `)
                 -   Basic and Diluted                                           35         268.50        33.56
             Notes forming part of the Standalone Financial Statements          1-46
             As per our report of even date attached                      For and on behalf of the Board
             For B S R & Co. LLP
             Chartered Accountants                                        Padmini Khare Kaicker  Director
             Firm's Registration No: 101248W/W - 100022
                                                                          R. Mukundan       Managing Director and CEO
             Vijay Mathur                                                 John Mulhall      Chief Financial Officer
             Partner
             Membership No. 046476                                        Rajiv Chandan     General Counsel &
             Mumbai, May 15, 2020                                                           Company Secretary

                                                                                                            175
   172   173   174   175   176   177   178   179   180   181   182